BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodriguez‐otormin F, Duro‐castano A, Conejos‐sánchez I, Vicent MJ. Envisioning the future of polymer therapeutics for brain disorders. WIREs Nanomed Nanobiotechnol 2019;11. [DOI: 10.1002/wnan.1532] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Faouzi A, Roullin VG. Think Big, Start Small: How Nanomedicine Could Alleviate the Burden of Rare CNS Diseases. Pharmaceuticals (Basel) 2021;14:109. [PMID: 33573213 DOI: 10.3390/ph14020109] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Melnyk T, Đorđević S, Conejos-Sánchez I, Vicent MJ. Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation. Adv Drug Deliv Rev 2020;160:136-69. [PMID: 33091502 DOI: 10.1016/j.addr.2020.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
3 Cuesta CM, Ibañez F, Lopez-Hidalgo R, Ureña J, Duro-Castano A, Armiñán A, Vicent MJ, Pascual M, Guerri C. A targeted polypeptide-based nanoconjugate as a nanotherapeutic for alcohol-induced neuroinflammation. Nanomedicine 2021;34:102376. [PMID: 33667725 DOI: 10.1016/j.nano.2021.102376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhou X, Smith QR, Liu X. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1695. [PMID: 33470550 DOI: 10.1002/wnan.1695] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zhang L, Sun H, Chen Y, Wei M, Lee J, Li F, Ling D. Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1696. [PMID: 33463089 DOI: 10.1002/wnan.1696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang L, Sun H, Zhao J, Lee J, Ee Low L, Gong L, Chen Y, Wang N, Zhu C, Lin P, Liang Z, Wei M, Ling D, Li F. Dynamic nanoassemblies for imaging and therapy of neurological disorders. Adv Drug Deliv Rev 2021;175:113832. [PMID: 34146626 DOI: 10.1016/j.addr.2021.113832] [Reference Citation Analysis]
7 Spencer AP, Torrado M, Custódio B, Silva-Reis SC, Santos SD, Leiro V, Pêgo AP. Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System. Pharmaceutics 2020;12:E192. [PMID: 32102252 DOI: 10.3390/pharmaceutics12020192] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
8 Pascual M, Calvo-Rodriguez M, Núñez L, Villalobos C, Ureña J, Guerri C. Toll-like receptors in neuroinflammation, neurodegeneration, and alcohol-induced brain damage. IUBMB Life 2021;73:900-15. [PMID: 34033211 DOI: 10.1002/iub.2510] [Reference Citation Analysis]
9 Duro-Castano A, Moreira Leite D, Forth J, Deng Y, Matias D, Noble Jesus C, Battaglia G. Designing peptide nanoparticles for efficient brain delivery. Adv Drug Deliv Rev 2020;160:52-77. [PMID: 33031897 DOI: 10.1016/j.addr.2020.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
10 Duro-Castano A, Borrás C, Herranz-Pérez V, Blanco-Gandía MC, Conejos-Sánchez I, Armiñán A, Mas-Bargues C, Inglés M, Miñarro J, Rodríguez-Arias M, García-Verdugo JM, Viña J, Vicent MJ. Targeting Alzheimer's disease with multimodal polypeptide-based nanoconjugates. Sci Adv 2021;7:eabf9180. [PMID: 33771874 DOI: 10.1126/sciadv.abf9180] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Paudel YN, Angelopoulou E, Semple B, Piperi C, Othman I, Shaikh MF. Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological Disorders. ACS Chem Neurosci 2020;11:485-500. [PMID: 31972087 DOI: 10.1021/acschemneuro.9b00640] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]